CU20090059A7 - Quelatos metálicos con radical peg perfluorado, método para su preparación y su uso - Google Patents

Quelatos metálicos con radical peg perfluorado, método para su preparación y su uso

Info

Publication number
CU20090059A7
CU20090059A7 CU20090059A CU20090059A CU20090059A7 CU 20090059 A7 CU20090059 A7 CU 20090059A7 CU 20090059 A CU20090059 A CU 20090059A CU 20090059 A CU20090059 A CU 20090059A CU 20090059 A7 CU20090059 A7 CU 20090059A7
Authority
CU
Cuba
Prior art keywords
preparation
perfluorated
metal chelates
radical
peg
Prior art date
Application number
CU20090059A
Other languages
English (en)
Other versions
CU23837B1 (es
Inventor
Heiko Schirmer
Ludwig Zorn
Hanns-Joachim Weinmann
Johannes Platzek
Bernd Misselwitz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CU20090059A7 publication Critical patent/CU20090059A7/es
Publication of CU23837B1 publication Critical patent/CU23837B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención se relaciona con los objetos caracterizados en las reivindicaciones, específicamente con quelatos metálicos con radical PEG perfluorado, con métodos para su preparación y con su uso para diagnóstico NMR y por rayos-X, radiodiagnóstico y radioterapia y para linfografía MRT.
CU2009000059A 2006-10-18 2009-04-17 Quelatos metálicos con radical peg perfluorado CU23837B1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102006049821A DE102006049821A1 (de) 2006-10-18 2006-10-18 Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
US85296306P 2006-10-20 2006-10-20
US89007107P 2007-02-15 2007-02-15
PCT/EP2007/007284 WO2008046463A1 (de) 2006-10-18 2007-08-11 Metallchelate mit perfluoriertem peg-rest, verfahren zu deren herstellung sowie deren verwendung

Publications (2)

Publication Number Publication Date
CU20090059A7 true CU20090059A7 (es) 2011-03-21
CU23837B1 CU23837B1 (es) 2012-10-15

Family

ID=38670854

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2009000059A CU23837B1 (es) 2006-10-18 2009-04-17 Quelatos metálicos con radical peg perfluorado

Country Status (21)

Country Link
US (1) US8263040B2 (es)
EP (1) EP2089362A1 (es)
JP (1) JP5475454B2 (es)
KR (1) KR101451446B1 (es)
CN (1) CN101687803B (es)
AU (1) AU2007312691A1 (es)
BR (1) BRPI0717466A2 (es)
CA (1) CA2666910C (es)
CO (1) CO6170342A2 (es)
CR (1) CR10727A (es)
CU (1) CU23837B1 (es)
DE (1) DE102006049821A1 (es)
GT (1) GT200900087A (es)
IL (1) IL198173A0 (es)
MX (1) MX2009004097A (es)
MY (1) MY148553A (es)
NO (1) NO20091912L (es)
NZ (1) NZ576249A (es)
RU (1) RU2470014C2 (es)
SG (1) SG177994A1 (es)
WO (1) WO2008046463A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021948A1 (en) * 2007-08-13 2009-02-19 Ge Healthcare As Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
US11529309B2 (en) * 2016-04-29 2022-12-20 University Of Houston System Compositions, methods and kits for treating a contact lens
KR102268922B1 (ko) * 2018-05-16 2021-06-24 광저우 유알 매터리얼 테크놀로지 컴퍼니 리미티드 퍼플루오로폴리에테르기 함유 실란화합물, 이의 제조방법, 표면처리제 및 물품
WO2020203671A1 (ja) * 2019-03-29 2020-10-08 ダイキン工業株式会社 フルオロポリエーテル基含有化合物
JPWO2025058000A1 (es) 2023-09-13 2025-03-20

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588279A (en) 1982-10-27 1986-05-13 Konishiroku Photo Industry Co., Ltd. Cleaning roller intermediate transfer member
US4586511A (en) 1983-03-04 1986-05-06 Children's Hospital Medical Center Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance
US4639364A (en) 1984-11-14 1987-01-27 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
EP0292306A3 (en) 1987-05-20 1989-09-13 Nippon Shokubai Co., Ltd. Methylolaminotriazine condensates and method for production thereof
US4838274A (en) 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE4008179A1 (de) 1990-03-12 1991-09-19 Schering Ag Fluorbenzolsulfonamide
US5250283A (en) 1990-03-28 1993-10-05 Molecular Biosystems, Inc. Organic contrast agent analog and method of making same
US5318770A (en) 1991-10-25 1994-06-07 Mallinckrodt Medical, Inc. Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging
DE4203254C2 (de) 1992-02-05 1996-05-02 Max Planck Gesellschaft Fluorhaltige Markierungsverbindung für NMR-Untersuchungen und deren Verwendung
US5482650A (en) * 1992-04-28 1996-01-09 Minnesota Mining And Manufacturing Company Liquid crystal compounds having perfluoroether terminal portions
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5401493A (en) 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
DE4317588C2 (de) 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
US5502094A (en) 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5702637A (en) 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
DE19744003B4 (de) 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19744004C1 (de) 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
ES2206996T3 (es) 1997-10-02 2004-05-16 Epix Medical Inc Metodo de formacion de imagenes para diagnostico con contraste mejorado para monitorizar terapias de intervencion.
DE19914101C1 (de) 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19948651B4 (de) 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6939329B1 (en) 1999-10-08 2005-09-06 Harvest Technologies Corporation Apparatus for holding and operating one or more syringes
DE10040858C2 (de) 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
RU2206605C1 (ru) * 2002-03-18 2003-06-20 Здоров Юрий Павлович Противоизносная присадка к смазочным средам и топливу
US7090829B2 (en) * 2002-04-11 2006-08-15 Carbomer, Inc. Imaging probes
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
JP2004101881A (ja) * 2002-09-10 2004-04-02 Konica Minolta Holdings Inc ドライイメージング材料
AU2005209169B2 (en) 2004-01-16 2010-12-16 Carnegie Mellon University Cellular labeling for nuclear magnetic resonance techniques
RU2296756C2 (ru) * 2005-05-17 2007-04-10 Федеральное унитарное государственное предприятие "Государственный научно-исследовательский институт биологического приборостроения" (ГосНИИ БП) Комплексообразующие дибензосодержащие пятичленные циклические соединения, содержащие два симметричных бета-дикарбонильных заместителя с фторированными радикалами

Also Published As

Publication number Publication date
NO20091912L (no) 2009-07-17
CN101687803B (zh) 2012-05-30
HK1141526A1 (en) 2010-11-12
EP2089362A1 (de) 2009-08-19
CA2666910C (en) 2013-12-24
CA2666910A1 (en) 2008-04-24
JP2010506862A (ja) 2010-03-04
IL198173A0 (en) 2009-12-24
MX2009004097A (es) 2009-07-10
NZ576249A (en) 2012-03-30
RU2470014C2 (ru) 2012-12-20
CN101687803A (zh) 2010-03-31
CO6170342A2 (es) 2010-06-18
AU2007312691A1 (en) 2008-04-24
DE102006049821A1 (de) 2008-04-24
US20080159954A1 (en) 2008-07-03
MY148553A (en) 2013-04-30
JP5475454B2 (ja) 2014-04-16
KR101451446B1 (ko) 2014-10-16
GT200900087A (es) 2010-04-19
US8263040B2 (en) 2012-09-11
RU2009118486A (ru) 2010-11-27
WO2008046463A1 (de) 2008-04-24
CR10727A (es) 2009-07-23
SG177994A1 (en) 2012-02-28
CU23837B1 (es) 2012-10-15
KR20090082222A (ko) 2009-07-29
BRPI0717466A2 (pt) 2014-04-15

Similar Documents

Publication Publication Date Title
MX2012009088A (es) Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
CY1125550T1 (el) Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
CR20110558A (es) ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS Y MÉTODOS DE USO
PL2371385T3 (pl) Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
AR090923A1 (es) Anticuerpos anti-il-23
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
CO7121325A2 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
BRPI1014800A2 (pt) "composições compreendendo alfa-(1,6) oli-godextranas alfa-(1,2) ramificadas, método para preparar as referidas oligodextranas e uso das mesmas"
UY33124A (es) Agentes y epítopos enlazados a wise
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
BRPI0910030A2 (pt) método de teste ultra-sônico e equipamento para o mesmo.
MX2012007041A (es) Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).
BR112012027574A2 (pt) aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos
MX374249B (es) Nuevos compuestos de quelato de gadolinio para usar en imágenes de resonancia magnética.
BR112014008089A2 (pt) método para diagnosticar o mal de alzheimer, uso do método, e, kit para a realização do método
HRP20190045T1 (hr) Metode i sastavi za liječenje upalne bolesti crijeva
CR10727A (es) Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
CR9645A (es) Complejos con contenido de perfluoroalquilo, procedimientos para su preparacion asi como su uso
ES2534911T3 (es) Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía
BRPI0922908A2 (pt) "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste".

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)